Candesartan cilexetil in children with hypertension or proteinuria: preliminary data

@article{Simonetti2006CandesartanCI,
  title={Candesartan cilexetil in children with hypertension or proteinuria: preliminary data},
  author={Giacomo Domenico Simonetti and Rodo O. von Vigier and Martin A Konrad and Mattia Rizzi and Emilio Filippo Fossali and Mario G Bianchetti},
  journal={Pediatric Nephrology},
  year={2006},
  volume={21},
  pages={1480-1482}
}
The angiotensin II receptor blockers irbesartan and losartan effectively reduce blood pressure and proteinuria in childhood. We were impressed by the neutral taste and the small size of the candesartan cilexetil tablets. This angiotensin II receptor blocker was used during 4 months in 17 pediatric patients (aged 0.5–16, median 4.5 years) with chronic arterial hypertension (n=6), overt proteinuria (n=2), or both (n=9). The initial candesartan dose of 0.23 (0.16–0.28) mg/kg body weight once daily… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Angiotensin II receptor antagonist treatment during pregnancy.

Birth defects research. Part A, Clinical and molecular teratology • 2005
View 1 Excerpt

“Why do they do that?”

Pediatric Nephrology • 2005
View 2 Excerpts

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises

BF Palmer
Nephrol Dial Transplant • 2003
View 1 Excerpt

Similar Papers

Loading similar papers…